Tag : Board

CCT Impact

Aurora Cannabis Announces New Director and Updates to The Board

CCT IMPACT Agent
Aurora Cannabis Inc. (the “Company” or “Aurora“) (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the appointment of Chitwant Kohli to the Company’s Board of Directors (the “Board”), effective today. This is a newly added position that expands the Board to nine members, seven of whom are independent.   Mr. Kohli joins the Board following a fulsome......
CCT Impact

Humble & Fume Inc. Appoints New Chairman of the Board: Jakob Ripshtein, CEO of Perennial Brands Inc

CCT IMPACT Agent
Humble & Fume Inc. (CSE: HMBL) (“Humble” or the “Company”), a leading North American distributor of cannabis and cannabis accessories, is proud to announce the appointment of Jakob Ripshtein as Chairman of the Board (the “Board”) effective today. Mr. Ripshtein succeeds outgoing Executive Chairman, Shawn Dym, Principle at York Plains Investments, who remains......
CCT Impact

Hollister Biosciences Inc. Announces strategic initiatives including a planned rebrand, executive and board updates

CCT IMPACT Agent
Hollister Biosciences Inc. (CSE: HOLL) (OTC: HSTRF) (FRANKFURT: HOB) (the “Company“, “Hollister Cannabis Co.” or “Hollister“) is pleased to announce a series of operational and strategic updates to create shareholder value, enhance; governance, operations and market positioning while preparing the Company for the next phase of its growth. Background In November......
CCT Impact

Delic Announces Medical Advisory Board, Demonstrates Psychedelic Wellness Company’s Commitment to Science

CCT IMPACT Agent
Delic Holdings Corp (“Delic” or the “Company“) (CSE: DELC) (OTCQB: DELCF), the leading psychedelic wellness platform today announced the formation of a Medical Advisory Board. The diverse advisory board consists of MDs, PhDs and others who specialize in psychedelic wellness and addition. The Board will advise Delic and its subsidiaries, including Ketamine......
CCT Impact

Delic Announces Ifetayo Harvey–Drug Reform Advocate and Founder and Board President of the People of Color Psychedelic Collective–to Speak at Meet Delic: The World’s Premiere Psychedelic and Wellness Event

CCT IMPACT Agent
Delic Holdings Inc. (“DELIC” or the “Company”) (CSE: DELC) (OTCQB: DELCF), the leading psychedelic wellness platform, today announced that Ifetayo Harvey will serve as one of the event’s mainstage speakers. Meet Delic is the world’s premiere psychedelic and wellness edutainment event catering to both curious newcomers, businesses and thought leaders. Harvey is the Founder and Board......
CCT Impact

Blake Cantrell of The Peak Dispensary Appointed to OMMA Advisory Board

CCT IMPACT Agent
The Peak Dispensary, an Oklahoma City, OK based chain of medical cannabis dispensaries, is excited to announce the company’s CEO, Blake Cantrell, has been appointed to OMMA’s Food Safety Standards Board. FSSB, more often referred to as the OMMA Advisory Board, is comprised of state officials, experts, and OMMA-licensed cannabis industry representatives. The......
CCT Impact

Former Questex CEO Kerry Gumas Joins Jage Media Board

CCT IMPACT Agent
Jage Media, a B2B media company that produces distinctive events and focused content that accelerate the growth and profitability of cannabis brands and retailers, announces the election of Kerry Gumas to its Board of Directors. “Kerry brings extensive experience from decades on launching, building, and optimizing trade shows and related media assets,”......
CCT Impact

Item 9 Labs Adds Expertise To Strengthen Its Board Of Directors

CCT IMPACT Agent
Item 9 Labs Corp. (OTCQX: INLB) (“Item 9 Labs” or the “Company”), a vertically integrated cannabis dispensary franchisor and operator that produces premium, award-winning products, announced today that law enforcement veteran Joe DiSalvo and the Company’s Chief Franchise Officer Mike Weinberger have been appointed to its Board of Directors. DiSalvo’s appointment demonstrates the Company’s focus on strengthening its corporate governance through more......
CCT Impact

Cannabis Patient Care™ Announces Members of Editorial Advisory Board

CCT IMPACT Agent
Cannabis Patient Care™, a leading multimedia platform dedicated to advancing medical research, education, and treatment in the cannabis industry, is pleased to officially announce the first eight members of its newly launched editorial advisory board. “We are very grateful to welcome eight talented and well-respected members of the cannabis industry to our......
CCT Impact

Body and Mind Strengthens Board with Veteran Cannabis Executive

CCT IMPACT Agent
Body and Mind Inc. (CSE: BAMM) (OTCQB: BMMJ) (the “Company” or “BaM”), a multi-state operator focused on limited license markets is please to report that Alexis Podesta, who was instrumental in California’s transition from medical to adult use cannabis, has been appointed as a director of the Company. Alexis Podesta has served in senior roles in both the......